Pathologia is a prominent open-access journal dedicated to advancing the field of clinical and experimental pathology, published by ZAPORIZHZHYA STATE MEDICAL UNIVERSITY. Established in 2013, the journal aims to provide a platform for researchers, clinicians, and students to share innovative research, case studies, and reviews that are critical to understanding disease mechanisms and improving diagnostic and therapeutic strategies. With a steady commitment to high-quality research dissemination and accessibility, this journal serves as an essential resource for those in the medical and health sciences fields. Researchers engaging with Pathologia can explore a diverse range of topics, including histopathology, molecular pathology, and laboratory medicine, promoting both scholarly discussion and practical applications. The journal's open-access model ensures that vital research findings are freely available to the global academic community, fostering a collaborative environment that is crucial for the advancement of pathology as a discipline.

CURRENT OPINION IN INFECTIOUS DISEASES, published by Lippincott Williams & Wilkins, is a premier journal that focuses on the latest developments and understanding in the field of infectious diseases. With its ISSN 0951-7375 and E-ISSN 1473-6527, this journal has gained recognition for its pivotal role in advancing knowledge from 1988 to its current publications in 2024. Boasting an impressive Q1 ranking in both Infectious Diseases and the Medical Microbiology category, it holds a reputable position among the top journals in the field. The journal serves as an essential resource for researchers, professionals, and students alike, providing them with timely reviews, analyses, and perspectives that shape contemporary practice and policy. While lacking open access options, it ensures a critical examination of emerging trends and unique insights that foster informed discussions. With its consistently high impact factor, CURRENT OPINION IN INFECTIOUS DISEASES remains a vital platform for thought leaders and innovators navigating the complexities of infectious disease research.

SYDOWIA is a prestigious academic journal based in Austria, published by Verlag Ferdinand Berger Sohne Gesellschaft mbH, that has been a cornerstone of scientific publishing since its establishment in 1996. With an ISSN of 0082-0598, SYDOWIA focuses on critical research in the fields of Ecology, Evolution, Behavior and Systematics as well as Plant Science, earning a notable classification in Category Quartiles with Q3 in Ecology-related disciplines and Q2 in Plant Science for 2023. The journal’s strategic insights into agricultural and biological sciences have secured a place within the Scopus rankings, where it holds the position of #191 out of 516 in Plant Science and #278 out of 721 in Ecology categories—reflecting its growing influence with a percentile standing of 63rd and 61st, respectively. Although SYDOWIA is not an Open Access journal, it continues to thrive in delivering scholarly articles that promote advancement and innovation in ecological and botanical research. Researchers, professionals, and students alike can rely on SYDOWIA as a vital resource for disseminating knowledge and fostering exploration in these essential scientific domains.

Welcome to the Journal of Microbiology Immunology and Infection, a premier academic publication established in 1998 and now proudly owned by Elsevier Taiwan. As an Open Access journal since 2016, it provides unrestricted access to groundbreaking research in the fields of immunology, microbiology, and infectious diseases, making it an essential resource for researchers, practitioners, and students alike. The journal holds impressive rankings, including Q1 status in categories such as Infectious Diseases and Microbiology (medical), and a notable 92nd percentile in its Scopus ranking for Medicine - Infectious Diseases. With a dedicated focus on advancing knowledge and fostering collaboration within the scientific community, the Journal of Microbiology Immunology and Infection is committed to publishing high-impact research that significantly influences practice and policy in healthcare and life sciences. The journal is also recognized for its contribution to the ongoing dialogue surrounding contemporary issues in immunology and infection, positioning it as a vital platform for scholarly exchange and innovation.

JOURNAL DE MYCOLOGIE MEDICALE is a premier publication in the field of infectious diseases, particularly focusing on the study of mycology and its clinical implications. Published by MASSON EDITEUR, this esteemed journal is based in France and has been disseminating valuable research since its inception in 1994. With an ISSN of 1156-5233 and an E-ISSN of 1773-0449, it plays a critical role in advancing knowledge in mycological infections, positioning itself in the Q3 category for infectious diseases as per the 2023 quartiles. As indicated by its ranking in Scopus, ranking #142 out of 344 in the medicine-infectious diseases category, the journal maintains a prominent presence within the academic community, appealing to researchers, healthcare professionals, and students alike. Although access options are not open access, the journal endeavors to promote a deeper understanding of mycological studies that are crucial for combating ongoing and emerging infectious threats. As it continues to converge on new findings up to 2024, JOURNAL DE MYCOLOGIE MEDICALE remains an essential resource for those invested in the critical intersections of mycology and medicine.

MycoKeys, published by PENSOFT PUBLISHERS, is a leading open-access journal dedicated to advancing the understanding of fungal biology and its diverse implications within agricultural, ecological, and biological sciences. With its ISSN 1314-4057 and E-ISSN 1314-4049, this journal has achieved remarkable academic prestige, reflected in its 2023 Scopus rankings placing it in the first quartile (Q1) across several categories, including Agricultural and Biological Sciences (miscellaneous), Ecology, Evolution, Behavior and Systematics, and Plant Science. MycoKeys provides a platform for researchers, professionals, and students interested in the latest findings and methodologies regarding fungi, their environments, and their interactions within various ecosystems. Since its transition to open access in 2011, the journal has championed the dissemination of high-quality research to a global audience, fostering collaboration and innovation in mycology. With a publishing history that converges from 2015 to 2024, MycoKeys remains a vital resource for those committed to exploring the multifaceted roles fungi play in our world.

MYCOTAXON is a peer-reviewed journal dedicated to the field of mycology, focusing on the taxonomy, systematics, and ecology of fungi. Published by MYCOTAXON LTD, this journal plays a crucial role in advancing our understanding of fungal biodiversity and its significance within various ecosystems. Although it currently does not offer open access options, its contributions are vital to the scientific community, especially with its established presence since 1989. With an HIndex reflecting its relevance and attracting a dedicated readership, MYCOTAXON is recognized within the Q4 quartile in both Ecology, Evolution, Behavior, and Systematics, and Plant Science categories as of 2023. This places it among a critical cohort of journals that contribute to the understanding of ecological dynamics and plant-fungal interactions. Researchers, professionals, and students can benefit from the insights provided in MYCOTAXON, making it an indispensable resource for anyone involved in the study of fungi.

Frontiers in Fungal Biology is an innovative academic journal dedicated to advancing the field of mycology and its interdisciplinary connections, published by FRONTIERS MEDIA SA. With an E-ISSN of 2673-6128, this journal focuses on exploring diverse aspects of fungal biology, including ecological roles, evolutionary processes, and interactions with other organisms. Since its inception in 2020, Frontiers in Fungal Biology has garnered attention within the scientific community, earning a commendable Q2 ranking in both Ecology, Evolution, Behavior and Systematics, and Environmental Science categories in 2023, alongside respectable Q3 rankings in Infectious Diseases and Microbiology. The journal is committed to open access principles, making cutting-edge research freely available to a global audience, promoting knowledge sharing and collaboration. By providing a platform for rigorous research and impactful discussions, Frontiers in Fungal Biology aims to enhance the understanding of fungi and their significant roles in ecosystems, health, and biotechnology, appealing to researchers, professionals, and students alike.

Journal of Fungi is a premier open-access journal published by MDPI, dedicated to advancing the understanding of fungal biology in its myriad forms. Since its inception in 2015, it has become a vital resource in the fields of ecology, evolution, and plant sciences, attaining notable rankings in Scopus, including Q1 status in Ecology, Evolution, Behavior and Systematics, and Plant Science, with a Q2 ranking in Microbiology (medical). The journal fosters a collaborative platform for researchers, professionals, and students by providing unrestricted access to high-quality, peer-reviewed articles, which encourages the dissemination of innovative findings and methodologies relevant to fungal research. Designed to cater to a global audience, the Journal of Fungi has established its significance in the scientific community, especially from its base in Switzerland, where it continues to contribute to the ongoing discourse in mycology and beyond. With its commitment to open access since its launch and its continuous support for groundbreaking research, the journal plays a crucial role in driving forward the scientific inquiry and ecological awareness in fungal studies.

Research in Microbiology, published by Elsevier, is a prominent academic journal devoted to advancing the field of microbiology, encompassing a diverse array of topics including immunology, molecular biology, and biochemistry. Established in 1987, the journal has expanded its focus over the years, with a commendable impact factor reflecting its relevance and influence in the scientific community. Although it does not currently offer open access options, Research in Microbiology remains a crucial resource for researchers and professionals seeking to stay abreast of the latest findings and methodologies. The journal holds a respectable Q2 ranking in Medicine (miscellaneous) and a Q3 ranking in both Microbiology and Molecular Biology for 2023, highlighting its position within the scholarly landscape. With its base in France and accessible to a global audience, Research in Microbiology continues to foster scholarly exchange, making it an essential platform for the dissemination of impactful microbiological research.